WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, and chief strategy officer of AdvaMed, today issued the following statement regarding release of a discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA) in the U.S. House of Representatives:
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker in advance of House consideration tomorrow of the American Health Care Act:
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that CVRx President and CEO Nadim Yared has been named chairman of the AdvaMed Board of Directors for a two-year term.
Creating life-changing innovations is central to the role the medical technology industry plays in improving patient care. For people with neurological conditions — like spina bifida, epilepsy, Parkinson’s, multiple sclerosis and many others — advances in medical technology are not only improving, but also saving lives. Unbeknownst to many, however, is how one harmful tax policy is creating unnecessary barriers to future advances, and negatively affecting those living with chronic diseases and...
The United States has long been a leader in medical technology innovation and discovery, and Wisconsin has been a leading state in medical breakthroughs and medical device manufacturing.
Unfortunately, we have tax policies, including the medical device tax, that have stifled innovation and job creation, putting our research and technological leadership at risk.
From artificial joints to replacement heart valves, hospital beds to radiation therapies, the economic and human impact of medical technology innovation cannot be overstated. Medical technology companies that innovate quickly and at high levels of quality create and sustain well-paying jobs and, most importantly, save and improve the lives of patients. And that is why permanent repeal of the medical device tax must be a priority for the 115th Congress in 2017.
The 2.3 percent excise tax on...